Fruquintinib plus paclitaxel has shown promising results as a second-line treatment option for patients with advanced gastric or gastroesophageal junction (GEJ) cancer. The combination improved responses and progression-free survival (PFS) compared to paclitaxel alone, and there was a trend toward improved overall survival (OS) with fruquintinib. The FRUTIGA trial included 703 patients with advanced gastric…
The tech-enabled mental health platform Headlight has launched with $18 million in funding and offers in-network access to treatment for a variety of mental health conditions. The company aims to improve clinician and patient experience, and plans to use the funding to expand its reach nationally. UK-based SaaS company Lilli, which utilizes AI and machine…
The Food and Drug Administration is planning to propose a ban on formaldehyde in hair-straightening products, which are popular among Black women. The proposal comes after mounting evidence of health risks related to these products, including an increased risk of hormone-driven cancers. Critics say the proposed ban does not go far enough, as it focuses…
STAT publishes selected Letters to the Editor in response to First Opinion essays for robust, good-faith discussion. Jason Karlawish’s article on Aduhelm’s approval process raises concerns about the roles and incentives of pharmaceutical companies and the FDA. John Haaga supports Karlawish’s points and advocates for public funding of FDA and NIH research for objectivity. Adina…
John Humphrey Wilfred Shaw was a medical doctor who studied at St John’s College, Cambridge, and later joined St Bartholomew’s Hospital in London in 1953. He worked as a GP in Redhill for 34 years and was the managing partner from 1985. After retiring in 1997, he attended literature classes and did research, publishing several…
A study presented during the February 2024 session of the American Society for Clinical Oncology Plenary Series shows that triplet therapy of belantamab mafodotin (belamaf) plus bortezomib and dexamethasone significantly improves outcomes for patients with relapsed or refractory multiple myeloma (RRMM), with an acceptable safety profile. The trial found that the median progression-free survival (PFS)…
Distek, Inc. introduces the BIOne 250 Bioprocess Controller, a cost-effective solution for microbial bioprocessing. This model is a process optimized design of the BIOne 1250 benchtop bioreactor system, with a user-friendly interface and scalability for evolving needs. It offers sophisticated functionality and integrates with other bioprocess equipment. The controller’s reliability and precision ensure consistent and…
George Kramb, 29, from San Diego, struggled with what he thought was severe dry skin for years. It was flaky, irritated, and cracked, especially in the winter. He tried over-the-counter ointments without success until he was diagnosed with atopic dermatitis (AD) in his teens. AD causes itchy rashes, skin discoloration, pain, and thickened skin. It’s…
A study found that over half of over-the-counter topical scar products contain allergens. Researchers searched for scar products on various retail websites and found 156 products. Of those, 55.2% contained at least one North American Contact Dermatitis Group (NACDG) allergen, with fragrance, phenoxyethanol, parabens, panthenol, and sodium benzoate being the most common. The study also…
Nutrition is crucial for overall health and well-being, especially when it comes to heart health. To improve heart health through diet, it is important to understand expert recommendations on what to eat and what to avoid. Heart-healthy foods include sardines, green tea, and flaxseeds, while it is important to limit the intake of high-fat dairy…
